Adequan Is Making It Rain on Eventers With Futures Team Challenge, AEC Sponsorships

Thank you, Adequan, for your continued support of our sport! The makers of those little vials of i.m. polysulfated glycosaminoglycan that keep our horses’ joints feeling their best never fail to step up when we need them most, and on that note they have two big announcements this week:

Clear (or even clear-ish) round, big check, can’t lose! The stakes have been raised for the $60,000 Adequan USEA Advanced Final at the 2020 USEA American Eventing Championships presented by Nutrena Feeds, making it an irresistible draw for qualified horses and riders.

$60,000! Why wouldn’t you show up for this? Not only does the winner receive a fat $30,000 check, this year the remainder of the pot will be distributed as such that any competitor through 25th place will go home with at least enough prize money to cover their entry fee.

  • Champion: $30,000
  • Reserve Champion: $10,000
  • 3rd place: $5,000
  • 4th place: $2,500
  • 5th place: $1,000
  • 6th place: $800
  • 7th place: $750
  • 8th place: $600
  • 9th place through 25th place: $550 (entry fee) each

“We wanted to switch things up a bit and offer anyone that finishes the Advanced in the top 25 to at least get their $550 entry fee back,” explained USEA CEO Rob Burk in the announcement today here. “We’re giving back to more competitors who are able to show up and complete the division. The Champion and Reserve Champion will still walk away with the same large checks as we offered in 2019. This wouldn’t be possible without the support of Adequan and continues our tradition of giving back 100 percent of AEC sponsorship dollars received back to the AEC competitors.”

To qualify, competitors need to complete a minimum of two events without cross country jump penalties at any USEA Advanced horse trials, CCI4*-S, CCI4*-L , or CCI5*-L between March 1, 2019 and Aug. 18, 2020. A list of qualifying events can be viewed here.

AEC entries opened yesterday. Click here for all the info on this year’s event, taking place Aug. 25-30 athe Kentucky Horse Park.

[$60,000 Adequan USEA Advanced Final Extends Purse: Guarantees Entry Fee Back Through 25th Place!]

Also today, US Equestrian announced Adequan as a Title Sponsor for the USEF Futures Team Challenge for Eventing – West and East Coasts. The Futures Team Challenge is a component of the U.S. Eventing Pathway Program that offers athletes the opportunity to compete in a simulated team competition under the guidance of U.S. Performance Director Erik Duvander and U.S. Development and Emerging Coach Leslie Law.

It’s great to see Adequan investing not only in the top eventers of today, but in the top eventers of tomorrow as well. In addition to the USEF Futures Team Challenge, Adequan has been title sponsor of the North American Youth Championships for Eventing (sadly canceled this year).

“The Futures Team Challenge illustrates US Equestrian Federation’s dedication to continually advancing the eventing discipline,” says Allyn Mann, Director of Strategic Partnerships, American Regent Animal Health. “We share that dedication, which is why it’s such an honor to be involved in this unique opportunity to support the sport by helping prospective eventing team athletes elevate their skills.”

“We’re thrilled to have Adequan’s support as the new title sponsor of the USEF Futures Team Challenge for Eventing,” says US Equestrian CEO Bill Moroney. “Many of our eventing athletes depend on Adequan® i.m. to help keep their horses’ joints healthy so they can perform at their peak. It’s a natural fit to have Adequan’s support of this key component of our U.S. Eventing Pathway Program.”

The 2020 Futures Team Challenge events are scheduled for the Plantation Field International CCI4*-S and CCI3*-S (Sept. 17-20 in Unionville, Pa.) and Galway Downs International CCI4*-L and CCI3*-L (Oct. 29-Nov. 1 in Temecula, Calif.).

[US Equestrian Welcomes Adequan® as Title Sponsor for the USEF Futures Team Challenge for Eventing]

Thank you, Adequan! Learn more at the website here.

Comments